Back

Quadruple therapy with ARNI vs quadruple therapy with ACEI on cardiovascular outcomes for heart failure with reduced ejection fraction: a network meta-analysis

22 May 2022 (08:30 - 19:45)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Chronic Heart Failure 4 Pharmacotherapy HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Jesus Hernando Diaz Acevedo

hamil, Dalton (United States of America)

37 More presentations in this session

Presentation thumbnail
Position and cardiorenal mechanisms of uromodulin in heart failure
Doctor L. Emmens (Groningen, NL)
Abstract Slides
Presentation thumbnail
Bridge to cardiac transplantation with temporary mechanical circulatory support: trends and outcomes in Spain (2010-2020)
Doctor E. Barge Caballero (A Coruna, ES)
Abstract Slides
Presentation thumbnail
Hepatic T1-time is a strong and independent predictor of cardiovascular outcome in all-comers referred for cardiac magnetic resonance imaging
Doctor K. Mascherbauer (Vienna, AT)
Abstract Slides
Presentation thumbnail
Virtual management of HF outpatient during COVID-19 pandemic period: a comparison with traditional follow up
Doctor S. Prosperi (Rome, IT)
Abstract Slides
Presentation thumbnail
Longitudinal analysis of ejection fraction in heart failure with reduced ejection fraction patients: pharmacological treatment effects
Mr A. Hernandez-Vicente (Murcia, ES)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure ePosters - focus on Chronic Heart Failure 4

The Event

Event poster

Heart Failure 2022

22 May 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources